SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-24-000401
Filing Date
2024-04-01
Accepted
2024-04-01 16:31:04
Documents
106
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20231231x10k.htm   iXBRL 10-K 2556618
2 EX-23.1 tmb-20231231xex23d1.htm EX-23.1 2846
3 EX-23.2 tmb-20231231xex23d2.htm EX-23.2 2764
4 EX-31.1 tmb-20231231xex31d1.htm EX-31.1 11193
5 EX-31.2 tmb-20231231xex31d2.htm EX-31.2 11057
6 EX-32 tmb-20231231xex32.htm EX-32 8550
7 EX-97.1 tmb-20231231xex97d1.htm EX-97.1 50215
  Complete submission text file 0001410578-24-000401.txt   10555037

Data Files

Seq Description Document Type Size
8 EX-101.SCH tmb-20231231.xsd EX-101.SCH 91022
9 EX-101.CAL tmb-20231231_cal.xml EX-101.CAL 67675
10 EX-101.DEF tmb-20231231_def.xml EX-101.DEF 267067
11 EX-101.LAB tmb-20231231_lab.xml EX-101.LAB 732756
12 EX-101.PRE tmb-20231231_pre.xml EX-101.PRE 520993
110 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20231231x10k_htm.xml XML 1583825
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39752 | Film No.: 24809883
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)